Lung cancer is a fairly common malignancy. An early diagnosis and a reliable staging and
re-staging with the aim to detect both local and distant relapse are of utmost importance in …

More than one decade ago, introduction of integrated PET/CT scanners changed oncologic
imaging and oncologic patient management profoundly. With these systems, the metabolic …

Aim To evaluate the effect of the 18F-FDG PET-CT respiratory gating (4D) study in the
correct documentation of pulmonary lesions with faint uptake in standard PET-CT. Methods …

Aim: High-sensitivity hybrid positron emission tomography (PET) imaging using advanced
whole-body (WB) or total-body PET/computed tomography (CT) systems permits reducing …

Background Respiratory diseases are one of the leading causes of death worldwide, yet
effective treatment options remain limited. Although inflammation is thought to be a key …

Background An inflammatory reaction in the airways and lung parenchyma, comprised
mainly of neutrophils and alveolar macrophages, is present in some patients with chronic …

F18 Fluorodeoxyglucose (FDG) PET/CT is now widely used clinically and has revolutionized
tumor staging, restaging, treatment planning, and prognosis assessment in lung cancer and …

Background Respiratory motion is known to deteriorate positron emission tomography (PET)
images and may lead to potential diagnostic errors when a standardized uptake value (SUV) …

18 F-fluorodeoxryglucose (18 F-FDG) PET/CT imaging is routinely performed in the
evaluation of patients with known or suspected thoracic malignancy. Indications for its use …

Objective Respiratory motion in 18F-fluorodeoxyglucose positron emission
tomography/computed tomography (FDG PET/CT) induces blurred images, leading to errors …